Cynosure and Hahn & Company have recently announced their definitive merger agreement, bringing together the strengths of both companies. This strategic combination involves the integration of Cynosure and Lutronic, two global leaders in energy-based medical aesthetic treatment systems and related technologies. The resulting merged entity is set to become a worldwide leader in the field, boasting a diverse and innovative product portfolio and a commercial presence spanning over 130 countries.

This collaboration aims to provide customers and patients with an expanded range of products and consumables, enhanced clinical training and services, increased research and development capabilities, a broader global footprint, and a reinforced supply chain for seamless product and service continuity. The combined company, as a result of this strategic merger, is positioned to offer significant benefits to customers, partners, and employees.

Lutronic's mission to drive innovation and deliver exceptional products and customer service to aesthetics providers globally aligns with the goals of this strategic combination. The inclusion of Cynosure's cutting-edge medical device technology, robust commercial infrastructure, and strong brand-building capabilities is expected to broaden the product line and customer base on a global scale.

Throughout this merger process, PJT Partners LP served as the exclusive financial advisor to Lutronic, while Cleary Gottlieb Steen & Hamilton LLP and Kim & Chang provided legal advisory services to Lutronic and Hahn & Company.

Source: prnewswire.com